EN
HI
Summary
As of 6 Oct, 2026, Neuland Laboratories stock price is ₹21875. During the trading session, the stock has moved between an intraday low of ₹21090.00 and an intraday high of ₹21960.00. Over the last 52 weeks, Neuland Laboratories has traded between ₹11500.00 and ₹24225.00.
The stock has recorded a trading volume of 62,813 shares,. Its Average Traded Price (ATP) is ₹21601.54, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹21875.00.
Neuland Laboratories has an upper circuit limit of ₹25805.00 and a lower circuit limit of ₹17205.00. The total value traded stands at ₹135.69 CR, and the delivery percentage for the day is 53.97%.
The stock is currently traded with a market lot size of 1. Neuland Laboratories also offers a dividend yield of 0.16%.
Neuland Laboratories Share Price Chart
Neuland Laboratories Share Key Metrics
Volume
62813.00
Market Cap
28065.38 CR
LTQ@LTP
1@21875.00
ATP
21601.54
Var Margin
20.88 %
Circuit Range
17205-25805
Delivery %
53.97 %
Value
135.69 CR
ASM/GSM
No
Market Lot
1
Neuland Laboratories Fundamentals
P/E Ratio
55.41
P/B Ratio
13.64
Div. Yield
0.16
Sector P/E
42.73
Sector P/B
3.55
Sec. Div. Yield
0.52
Neuland Laboratories Resistance and Support
Pivot 21296.67
Resistance
First Resistance
21878.34
Second Resistance
22251.67
Third Resistance
22833.34
Support
First Support
20923.34
Second Support
20341.67
Third Support
19968.34
Neuland Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 05 2026 | 21500 | 21875 | 1.72% | 21960 | 21090 |
| Thu Oct 01 2026 | 21285 | 21505 | 0.73% | 21670 | 20715 |
| Wed Sep 30 2026 | 21375 | 21350 | -0.12% | 21600 | 21200 |
Neuland Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-10 | Quarterly Results |
| 2024-11-06 | Quarterly Results |
Neuland Laboratories News
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Neuland Laboratories has made its first commercial peptide manufacturing module operational. This accelerates its peptide manufacturing expansion, with plans for a second module to add significant capacity.
Sep 15 2026 10:27:21
Neuland Laboratories Ltd - 524558 - Disclosure Under Regulation 30 Of SEBI Listing Regulations
Neuland Labs' Board approved a capital expenditure of Rs. 126 crore for purchasing 134 acres of land at Auro Industrial City, Kakinada. This land acquisition is intended for the company's future expansion and will be financed through internal accruals.
Sep 07 2026 17:25:11
Neuland Laboratories Management
| Name | Position |
|---|---|
| Davuluri Rama Mohan Rao | Chairman |
| Davuluri Sucheth Rao | Vice Chairman |
Neuland Laboratories Similar Stocks
Wockhardt Ltd.
2063.50
-20.40 (0.98%)
Dr. Lal Pathlabs Ltd.
1971.30
-33.80 (1.69%)
Sai Life Sciences Ltd.
1511.30
-29.90 (1.94%)
Krishna Institute of Medical Sciences Ltd
705.45
-30.80 (4.18%)
Piramal Pharma Ltd.
194.89
-3.08 (1.56%)
Acutaas Chemicals Ltd.
3122.20
-74.30 (2.32%)
Rubicon Research Ltd.
1608.50
-22.40 (1.37%)
Granules India Ltd.
817.25
-4.50 (0.55%)
Caplin Point Laboratories Ltd.
2604.00
-27.90 (1.06%)
Shilpa Medicare Ltd.
1031.20
-32.90 (3.09%)
Neuland Laboratories FAQs
The Buying Price of Neuland Laboratories share is 21875 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Neuland Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Neuland Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Neuland Laboratories shares is 55.41. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Neuland Laboratories shares is 13.64. Useful to assess the stock's value relative to its book value.
To assess Neuland Laboratories’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Neuland Laboratories is 28065.38 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Neuland Laboratories share price is 24225.00 & 11500.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Neuland Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NEULANDLAB
Or Download Choice FinX App
Invest in NEULANDLAB
